As promising biosimilar therapies to treat inflammatory conditions become available next year, Cigna Pharmacy Management, which manages pharmacy benefits for some Cigna Healthcare clients, is announcing that it will add select biosimilars as preferred products on its commercial formularies at the same position as Humira.

Cigna Healthcare has found that the average annual price of therapy for specialty drugs is $38,000 per patient, which is 75 times higher than non-specialty prescription drugs.

To better understand OCD, we sat down with Dr. Jamie Feusner, chief medical officer at NOCD, an organization that provides evidence-based treatments for people with OCD, to talk about the condition, how it shows up in different people, and the causes, treatment, and side effects of living with it.

High medical costs are inevitable. But they’re also predictable and manageable with the right data. Employers must understand the needs of their employees, in order to anticipate, address and manage high medical costs.

Flu season is almost in full swing, and older adults, and seniors in particular, need to be extra cautious. To make a case for the flu vaccine among Medicare-eligible adults, we scoured the web for stats on some of the dangers that the flu poses for older adults, the complications it can cause, as well as the efficacy and benefits of getting the shot.

Looking for a Medicare Advantage plan? Understanding star ratings – and knowing where to find them – can help you select the plan that's best for you.

Monkeypox, also called MPX, has been making headlines as of late. But, what exactly is Monkeypox? How did it come about, and what does it look like when a person contracts it? We tapped the expertise of Dr. Mark Netoskie, a market medical executive at Cigna, to answer these questions and more.

The cost for prescription drugs can vary widely. But, there are steps that people can take to ensure they get the most bang for their buck. Below, we dive into some of the ways that you can save money at the pharmacy counter.

Biosimilars represent a meaningful opportunity to reduce drug spending by as much as $375 billion over the next decade. Cigna is committed to driving greater value and lower costs where clinically appropriate for our customers and clients. As a longtime advocate for greater availability of biosimilars, we have worked for a decade to advance the pathways needed to bring biosimilars to market.

At Cigna Healthcare, our diabetes care solutions are built around a whole-person health strategy. The aim is to help identify, prevent and manage diabetes by connecting individuals to the right level of care. We look at some of the ways our approach has helped patients save money, and improves medication adherence and health outcomes.